Biosketch / Results /

Robert Zurier

Adjunct Professor, Department of Medicine

Contact Info

Robert.Zurier@nyumc.org


Cannabinoids, inflammation, and fibrosis
Zurier, Robert B; Burstein, Sumner H. Cannabinoids, inflammation, and fibrosis. FASEB journal. 2016 Nov;30(11):3682-3689 (2262872)

Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity
Tepper, Mark A; Zurier, Robert B; Burstein, Sumner H. Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity. Bioorganic & medicinal chemistry. 2014 Jul 01;22(13):3245-3251 (1013102)

Treatment of rheumatoid arthritis with marine and botanical oils: an 18-month, randomized, and double-blind trial
Reed, George W; Leung, Katherine; Rossetti, Ronald G; Vanbuskirk, Susan; Sharp, John T; Zurier, Robert B. Treatment of rheumatoid arthritis with marine and botanical oils: an 18-month, randomized, and double-blind trial. Evidence-based complementary & alternative medicine : eCAM. 2014 ;2014:857456-857456 (959382)

Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids
Olendzki, Barbara C; Leung, Katherine; Van Buskirk, Susan; Reed, George; Zurier, Robert B. Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids. Evidence-based complementary & alternative medicine : eCAM. 2011 ;2011:827286-827286 (142157)

Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4
Zurier, Robert B; Sun, Yee-Ping; George, Kerri L; Stebulis, Judith A; Rossetti, Ronald G; Skulas, Ann; Judge, Erica; Serhan, Charles N. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. FASEB journal. 2009 May;23(5):1503-1509 (142158)